{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\", document_type = \"Notice\" and posted_year = 2015 sorted by posted_date descending", "rows": [["FDA-2015-D-4803-0001", "FDA", "FDA-2015-D-4803", "Public Notification of Emerging Postmarket Medical Device Signals \n(\"Emerging Signals''); Draft Guidance for Industry and Food and Drug \nAdministration Staff; Availability", "Notice", "Notice of Availability", "2015-12-31T05:00:00Z", 2015, 12, "2015-12-31T05:00:00Z", "2016-03-01T04:59:59Z", "2016-02-26T23:00:43Z", "2015-32920", 0, 0, "0900006481dde96a"], ["FDA-2010-D-0434-0028", "FDA", "FDA-2010-D-0434", "Acidified Foods; Draft Guidance for Industry; Withdrawal of Draft Guidance", "Notice", "Withdrawal", "2015-12-30T05:00:00Z", 2015, 12, "2015-12-30T05:00:00Z", null, "2015-12-30T14:04:06Z", "2015-32781", 0, 0, "0900006481ddb9fb"], ["FDA-2007-D-0369-0370", "FDA", "FDA-2007-D-0369", "Bioequivalence Recommendations for Paliperidone Palmitate; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2015-12-29T05:00:00Z", 2015, 12, "2015-12-29T05:00:00Z", "2016-03-01T04:59:59Z", "2016-02-29T22:00:18Z", "2015-32723", 0, 0, "0900006481dd74ac"], ["FDA-2015-N-4170-0001", "FDA", "FDA-2015-N-4170", "Establishment of a Public Docket; Clinical Trial Designs in Emerging\nInfectious Diseases", "Notice", "General Notice", "2015-12-29T05:00:00Z", 2015, 12, "2015-12-29T05:00:00Z", "2016-01-29T04:59:59Z", "2016-01-29T22:01:07Z", "2015-32724", 0, 0, "0900006481dd7a8b"], ["FDA-2013-N-0242-0005", "FDA", "FDA-2013-N-0242", "Agency Information Collection Activities: Proposed Collection; Comment Request; Current Good Manufacturing Practice for Positron Emission Tomography Drugs", "Notice", "60 Day Proposed Information Collection", "2015-12-29T05:00:00Z", 2015, 12, "2015-12-29T05:00:00Z", "2016-03-01T04:59:59Z", "2016-02-29T22:00:25Z", "2015-32685", 0, 0, "0900006481dd7930"], ["FDA-2012-N-1021-0016", "FDA", "FDA-2012-N-1021", "Medical Device User Fee and Modernization Act; Notice to Public of Web Site Location of Fiscal Year 2016 Proposed Guidance Development", "Notice", "Announcement", "2015-12-29T05:00:00Z", 2015, 12, "2015-12-29T05:00:00Z", "2016-03-01T04:59:59Z", "2016-04-29T16:00:21Z", "2015-32726", 0, 0, "0900006481dd79c0"], ["FDA-2014-D-1318-0001", "FDA", "FDA-2014-D-1318", "Electroconvulsive Therapy Devices for Class II Intended Uses: Draft Guidance for Industry, Clinicians, and FDA Staff; Availability", "Notice", "Notice of Availability", "2015-12-29T05:00:00Z", 2015, 12, "2015-12-29T05:00:00Z", "2016-03-29T03:59:59Z", "2016-03-29T04:00:44Z", "2015-32591", 0, 0, "0900006481dd7b15"], ["FDA-2013-E-1692-0006", "FDA", "FDA-2013-E-1692", "Determination of Regulatory Review Period for Purposes of Patent\nExtension; KADCYLA", "Notice", "Determinations", "2015-12-28T05:00:00Z", 2015, 12, "2015-12-28T05:00:00Z", "2016-02-27T04:59:59Z", "2015-12-28T14:36:14Z", "2015-32475", 0, 0, "0900006481dd3c17"], ["FDA-2013-E-1691-0006", "FDA", "FDA-2013-E-1691", "Determination of Regulatory Review Period for Purposes of Patent\nExtension; KADCYLA", "Notice", "Determinations", "2015-12-28T05:00:00Z", 2015, 12, "2015-12-28T05:00:00Z", "2016-02-27T04:59:59Z", "2015-12-28T19:47:01Z", "2015-32475", 0, 0, "0900006481dd3e06"], ["FDA-2015-P-1898-0003", "FDA", "FDA-2015-P-1898", "Determination That KYTRIL Granisetron Hydrochloride) Tablets, Equivalent 1 Milligram and 2 Milligram Base, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "Determinations", "2015-12-28T05:00:00Z", 2015, 12, "2015-12-28T05:00:00Z", null, "2015-12-28T14:45:44Z", "2015-32496", 0, 0, "0900006481dd3cba"], ["FDA-2015-N-0001-0114", "FDA", "FDA-2015-N-0001", "Externally-Led Patient-Focused Drug Development Meetings", "Notice", "Meeting", "2015-12-28T05:00:00Z", 2015, 12, "2015-12-28T05:00:00Z", null, "2015-12-28T19:43:09Z", "2015-32476", 0, 0, "0900006481dd3b75"], ["FDA-2015-D-4386-0001", "FDA", "FDA-2015-D-4386", "Deviation Reporting for Human Cells, Tissues, and Cellular and Tissue-Based Products; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2015-12-24T05:00:00Z", 2015, 12, "2015-12-24T05:00:00Z", "2016-03-24T03:59:59Z", "2016-03-22T18:00:26Z", "2015-32323", 0, 0, "0900006481dd00d7"], ["FDA-2015-N-2163-0004", "FDA", "FDA-2015-N-2163", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Hearing, Aging,\nand Direct-to-Consumer Television Advertisements", "Notice", "30 Day Proposed Information Collection", "2015-12-23T05:00:00Z", 2015, 12, "2015-12-23T05:00:00Z", "2016-01-23T04:59:59Z", "2015-12-23T14:41:50Z", "2015-32251", 0, 0, "0900006481dc96ef"], ["FDA-2015-D-4644-0001", "FDA", "FDA-2015-D-4644", "Draft Guidance for Industry on Advancement of Emerging Technology\nApplications To Modernize the Pharmaceutical Manufacturing Base;\nDraft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2015-12-23T05:00:00Z", 2015, 12, "2015-12-23T05:00:00Z", "2016-02-23T04:59:59Z", "2016-02-22T23:00:11Z", "2015-32316", 0, 0, "0900006481dc96eb"], ["FDA-2012-N-0873-0004", "FDA", "FDA-2012-N-0873", "Agency Information Collection Activities: Proposed Collection; Comment Request; Bar Code Label Requirement for Human Drug and Biological Products; Correction", "Notice", "Correction", "2015-12-23T05:00:00Z", 2015, 12, "2015-12-23T05:00:00Z", null, "2015-12-23T15:02:59Z", "2015-32252", 0, 0, "0900006481dc9731"], ["FDA-2013-E-1433-0004", "FDA", "FDA-2013-E-1433", "Determination of Regulatory Review Period for Purposes of Patent Extension: JETREA,", "Notice", "Determinations", "2015-12-23T05:00:00Z", 2015, 12, "2015-12-23T05:00:00Z", "2016-02-23T04:59:59Z", "2015-12-23T14:57:05Z", "2015-32247", 0, 0, "0900006481dc9730"], ["FDA-2013-E-1437-0004", "FDA", "FDA-2013-E-1437", "Determination of Regulatory Review Period for Purposes of Patent Extension: JETREA,", "Notice", "Determinations", "2015-12-23T05:00:00Z", 2015, 12, "2015-12-23T05:00:00Z", "2016-02-23T04:59:59Z", "2015-12-23T17:26:13Z", "2015-32247", 0, 0, "0900006481dcaddd"], ["FDA-2013-E-1435-0004", "FDA", "FDA-2013-E-1435", "Determination of Regulatory Review Period for Purposes of Patent Extension: JETREA,", "Notice", "Determinations", "2015-12-23T05:00:00Z", 2015, 12, "2015-12-23T05:00:00Z", "2016-02-23T04:59:59Z", "2015-12-23T17:24:27Z", "2015-32247", 0, 0, "0900006481dcaddc"], ["FDA-2012-N-0976-0004", "FDA", "FDA-2012-N-0976", "Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance: Emergency Use Authorization of Medical Products", "Notice", "60 Day Proposed Information Collection", "2015-12-23T05:00:00Z", 2015, 12, "2015-12-23T05:00:00Z", "2016-02-23T04:59:59Z", "2016-03-04T13:03:35Z", "2015-32253", 0, 0, "0900006481dc98b8"], ["FDA-2015-D-1211-0098", "FDA", "FDA-2015-D-1211", "Revised Recommendations for Reducing the Risk of Human  Immunodeficiency Virus Transmission by Blood and Blood Products;\nGuidance for Industry; Availability,", "Notice", "Notice of Availability", "2015-12-23T05:00:00Z", 2015, 12, "2015-12-23T05:00:00Z", null, "2023-02-28T14:29:06Z", "2015-32250", 0, 0, "0900006481dca583"], ["FDA-2015-N-0001-0113", "FDA", "FDA-2015-N-0001", "Allergenic Products Advisory Committee; Notice of Meeting", "Notice", "Meeting", "2015-12-21T05:00:00Z", 2015, 12, "2015-12-21T05:00:00Z", null, "2015-12-21T14:45:50Z", "2015-31894", 0, 0, "0900006481dbddb1"], ["FDA-2015-N-0001-0112", "FDA", "FDA-2015-N-0001", "Risk Communication Advisory Committee; Notice of Meeting", "Notice", "Meeting", "2015-12-21T05:00:00Z", 2015, 12, "2015-12-21T05:00:00Z", null, "2015-12-21T14:43:29Z", "2015-31893", 0, 0, "0900006481dbdd6f"], ["FDA-2015-N-0001-0111", "FDA", "FDA-2015-N-0001", "Peripheral and Central Nervous System Drugs Advisory Committee;\nNotice of Meeting", "Notice", "Meeting", "2015-12-18T05:00:00Z", 2015, 12, "2015-12-18T05:00:00Z", null, "2015-12-18T14:39:06Z", "2015-31825", 0, 0, "0900006481db9853"], ["FDA-2013-E-0474-0004", "FDA", "FDA-2013-E-0474", "Determination of Regulatory Review Period for Purposes of Patent\nExtension; XTANDI", "Notice", "Determinations", "2015-12-18T05:00:00Z", 2015, 12, "2015-12-18T05:00:00Z", "2016-02-17T04:59:59Z", "2015-12-18T14:43:32Z", "2015-31824", 0, 0, "0900006481db9890"], ["FDA-2015-N-4667-0001", "FDA", "FDA-2015-N-4667", "Determination That Vancomycin Hydrochloride Injection Drug Products,\nWere Not Withdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "Determinations", "2015-12-17T05:00:00Z", 2015, 12, "2015-12-17T05:00:00Z", null, "2015-12-17T15:25:02Z", "2015-31689", 0, 0, "0900006481db6c06"], ["FDA-2011-D-0597-0058", "FDA", "FDA-2011-D-0597", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Guidance for Industry on Oversight of\nClinical Investigations: A Risk-Based Approach to Monitoring", "Notice", "30 Day Proposed Information Collection", "2015-12-17T05:00:00Z", 2015, 12, "2015-12-17T05:00:00Z", "2016-01-20T04:59:59Z", "2015-12-17T14:54:03Z", "2015-31695", 0, 0, "0900006481db6a1d"], ["FDA-2011-D-0164-0011", "FDA", "FDA-2011-D-0164", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Guidance for\nIndustry on Safety Labeling Changes\u2014Implementation of Section 505(o)(4) of the Federal Food, Drug, and Cosmetic Act", "Notice", "30 Day Proposed Information Collection", "2015-12-17T05:00:00Z", 2015, 12, "2015-12-17T05:00:00Z", "2016-01-20T04:59:59Z", "2015-12-18T22:00:50Z", "2015-31696", 0, 0, "0900006481db6b0a"], ["FDA-2015-D-4562-0001", "FDA", "FDA-2015-D-4562", "Safety Assessment for Investigational New Drug Application Safety\nReporting; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2015-12-17T05:00:00Z", 2015, 12, "2015-12-17T05:00:00Z", "2016-02-17T04:59:59Z", "2016-02-17T22:01:26Z", "2015-31690", 0, 0, "0900006481db6ac5"], ["FDA-2010-D-0226-0026", "FDA", "FDA-2010-D-0226", "Medical Device ISO 13485:2003 Voluntary Audit Report Pilot Program;\nTermination of Pilot Program; Announcement of the Medical Device\nSingle Audit Program Operational Phase", "Notice", "Notice of Termination", "2015-12-17T05:00:00Z", 2015, 12, "2015-12-17T05:00:00Z", null, "2015-12-17T15:07:46Z", "2015-31692", 0, 0, "0900006481db6ac6"], ["FDA-2015-N-0001-0110", "FDA", "FDA-2015-N-0001", "The Twentieth Food and Drug Administration International Separation Science Society Symposium on the Interface of Regulatory and Analytical Sciences for Biotechnology Health Products\u2014WCBP 2016", "Notice", "Meeting", "2015-12-17T05:00:00Z", 2015, 12, "2015-12-17T05:00:00Z", null, "2015-12-17T15:20:47Z", "2015-31691", 0, 0, "0900006481db6bb8"], ["FDA-2001-N-0075-0016", "FDA", "FDA-2001-N-0075", "Import Tolerances; Extension of Comment Period", "Notice", "Notice of Extension", "2015-12-16T05:00:00Z", 2015, 12, "2001-12-07T05:00:00Z", "2002-03-12T04:59:59Z", "2015-12-16T22:01:08Z", null, 0, 0, "09000064804b8337"], ["FDA-2001-N-0075-0014", "FDA", "FDA-2001-N-0075", "Import Tolerances; Advance Notice of Proposed Rulemaking", "Notice", "General Notice", "2015-12-16T05:00:00Z", 2015, 12, "2001-08-10T04:00:00Z", "2001-12-02T04:59:59Z", "2015-12-16T22:01:04Z", null, 0, 0, "09000064804b8332"], ["FDA-2012-N-0873-0003", "FDA", "FDA-2012-N-0873", "Agency Information Collection Activities; Proposed Collection; Comment Request; Bar Code Label Requirement for Human Drug and Biological Products", "Notice", "60 Day Proposed Information Collection", "2015-12-15T05:00:00Z", 2015, 12, "2015-12-15T05:00:00Z", "2016-02-17T04:59:59Z", "2015-12-24T22:00:48Z", "2015-31402", 0, 0, "0900006481da73c2"], ["FDA-2014-E-0182-0006", "FDA", "FDA-2014-E-0182", "Determination of Regulatory Review Period for Purposes of Patent\nExtension; VIZAMYL", "Notice", "Determinations", "2015-12-15T05:00:00Z", 2015, 12, "2015-12-15T05:00:00Z", "2016-02-17T04:59:59Z", "2015-12-15T15:50:05Z", "2015-31401", 0, 0, "0900006481da740f"], ["FDA-2015-D-0288-0016", "FDA", "FDA-2015-D-0288", "Premarket Studies of Implantable Minimally Invasive Glaucoma Surgical\nDevices; Guidance for Industry and Food and Drug Administration Staff;\nAvailability", "Notice", "Notice of Availability", "2015-12-15T05:00:00Z", 2015, 12, "2015-12-15T05:00:00Z", null, "2015-12-15T15:30:27Z", "2015-31407", 0, 0, "0900006481da7326"], ["FDA-2015-N-4462-0001", "FDA", "FDA-2015-N-4462", "Point of Care Prothrombin Time/International Normalized Ratio Devices\nfor Monitoring Warfarin Therapy; Public Workshop; Request for Comments", "Notice", "Public Meetings", "2015-12-15T05:00:00Z", 2015, 12, "2015-12-15T05:00:00Z", "2016-02-26T04:59:59Z", "2015-12-15T15:12:03Z", "2015-31404", 0, 0, "0900006481da6b39"], ["FDA-2015-D-4561-0001", "FDA", "FDA-2015-D-4561", "Head Lice Infestation: Developing Drugs for Topical Treatment; Draft\nGuidance for Industry; Availability", "Notice", "Notice of Availability", "2015-12-15T05:00:00Z", 2015, 12, "2015-12-15T05:00:00Z", "2016-03-15T03:59:59Z", "2016-03-16T20:00:25Z", "2015-31406", 0, 0, "0900006481da7377"], ["FDA-2013-D-1143-0049", "FDA", "FDA-2013-D-1143", "Use of Nucleic Acid Tests To Reduce the Risk of Transmission of West Nile\nVirus From Living Donors of Human Cells, Tissues, and Cellular and\nTissue-Based Products; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2015-12-15T05:00:00Z", 2015, 12, "2015-12-15T05:00:00Z", "2016-03-15T03:59:59Z", "2016-08-31T16:43:07Z", "2015-31405", 0, 0, "0900006481da74bd"], ["FDA-2013-E-1575-0005", "FDA", "FDA-2013-E-1575", "Determination of Regulatory Review Period for Purposes of Patent\nExtension; RAXIBACUMAB", "Notice", "Determinations", "2015-12-15T05:00:00Z", 2015, 12, "2015-12-15T05:00:00Z", "2016-02-17T04:59:59Z", "2015-12-15T16:00:10Z", "2015-31400", 0, 0, "0900006481da7506"], ["FDA-2013-E-1694-0006", "FDA", "FDA-2013-E-1694", "Determination of Regulatory Review Period for Purposes of Patent\nExtension; Trivascular Ovation Abdominal Stent Graft System", "Notice", "Determinations", "2015-12-15T05:00:00Z", 2015, 12, "2015-12-15T05:00:00Z", "2016-02-17T04:59:59Z", "2015-12-15T15:20:17Z", "2015-31397", 0, 0, "0900006481da72c8"], ["FDA-2015-N-0001-0109", "FDA", "FDA-2015-N-0001", "Circulatory System Devices Panel of the Medical Devices Advisory \nCommittee; Notice of Meeting", "Notice", "Public Meetings", "2015-12-14T05:00:00Z", 2015, 12, "2015-12-14T05:00:00Z", null, "2015-12-14T14:54:07Z", "2015-31372", 0, 0, "0900006481da1ef0"], ["FDA-1998-N-0088-0026", "FDA", "FDA-1998-N-0088", "Exports: Notification and Recordkeeping Requirements; Final Rule", "Notice", "Notice of Final Rule", "2015-12-14T05:00:00Z", 2015, 12, "2015-12-14T05:00:00Z", null, "2015-12-14T15:16:02Z", null, 0, 0, "0900006480585e1f"], ["FDA-2014-E-0309-0006", "FDA", "FDA-2014-E-0309", "Determination of Regulatory Review Period for Purposes of Patent\nExtension; FULYZAQ", "Notice", "Determinations", "2015-12-10T05:00:00Z", 2015, 12, "2015-12-10T05:00:00Z", "2016-02-09T04:59:59Z", "2015-12-10T17:04:57Z", "2015-31097", 0, 0, "0900006481d9aed7"], ["FDA-2014-E-0308-0006", "FDA", "FDA-2014-E-0308", "Determination of Regulatory Review Period for Purposes of Patent\nExtension; FULYZAQ", "Notice", "Determinations", "2015-12-10T05:00:00Z", 2015, 12, "2015-12-10T05:00:00Z", "2016-02-09T04:59:59Z", "2015-12-10T17:02:40Z", "2015-31097", 0, 0, "0900006481d9ac0d"], ["FDA-2014-E-0265-0005", "FDA", "FDA-2014-E-0265", "Determination of Regulatory Review Period for Purposes of Patent\nExtension; SIRTURO", "Notice", "Determinations", "2015-12-10T05:00:00Z", 2015, 12, "2015-12-10T05:00:00Z", "2016-02-09T04:59:59Z", "2015-12-10T16:59:04Z", "2015-31098", 0, 0, "0900006481d9ac0e"], ["FDA-2014-E-0279-0006", "FDA", "FDA-2014-E-0279", "Determination of Regulatory Review Period for Purposes of Patent\nExtension; ELIQUIS", "Notice", "Determinations", "2015-12-10T05:00:00Z", 2015, 12, "2015-12-10T05:00:00Z", "2016-02-09T04:59:59Z", "2015-12-10T19:24:05Z", "2015-31096", 0, 0, "0900006481d9ab78"], ["FDA-2014-E-0271-0006", "FDA", "FDA-2014-E-0271", "Determination of Regulatory Review Period for Purposes of Patent\nExtension; ARGUS II VISUAL STIMULATION SYSTEM", "Notice", "Determinations", "2015-12-10T05:00:00Z", 2015, 12, "2015-12-10T05:00:00Z", "2016-02-09T04:59:59Z", "2015-12-10T17:09:17Z", "2015-31095", 0, 0, "0900006481d9ac0b"], ["FDA-2013-N-0093-0006", "FDA", "FDA-2013-N-0093", "Agency Information Collection Activities: Proposed Collection;\nComment Request; Evaluation of the Program for Enhanced Review\nTransparency and Communication for New Molecular Entity New Drug\nApplications and Original Biologics License Applications in Prescription\nDrug User Fee Acts", "Notice", "60 Day Proposed Information Collection", "2015-12-10T05:00:00Z", 2015, 12, "2015-12-10T05:00:00Z", "2016-02-09T04:59:59Z", "2015-12-10T17:15:29Z", "2015-31100", 0, 0, "0900006481d9ab7a"], ["FDA-2013-E-1573-0005", "FDA", "FDA-2013-E-1573", "Determination of Regulatory Review Period for Purposes of Patent\nExtension; VERAFLOX", "Notice", "Determinations", "2015-12-10T05:00:00Z", 2015, 12, "2015-12-10T05:00:00Z", "2016-02-09T04:59:59Z", "2015-12-10T16:53:17Z", "2015-31099", 0, 0, "0900006481d9ac55"], ["FDA-2015-D-4380-0001", "FDA", "FDA-2015-D-4380", "Best Practices for Communication Between Investigational New Drug\nSponsors and Food and Drug Administration During Drug Development; Draft Guidance for Industry and Review Staff; Availability", "Notice", "Notice of Availability", "2015-12-09T05:00:00Z", 2015, 12, "2015-12-09T05:00:00Z", "2016-02-09T04:59:59Z", "2016-02-08T22:00:59Z", "2015-30931", 0, 0, "0900006481d9267b"], ["FDA-2015-N-2881-0002", "FDA", "FDA-2015-N-2881", "Standards-Based Approach to Analytical Performance Evaluation of\nNext Generation Sequencing in Vitro Diagnostic Tests; Public Workshop;\nReopening of Comment Period", "Notice", "Extension of Comment Period", "2015-12-09T05:00:00Z", 2015, 12, "2015-12-09T05:00:00Z", "2015-12-25T04:59:59Z", "2015-12-25T22:00:33Z", "2015-30937", 0, 0, "0900006481d92514"], ["FDA-2015-D-2261-0008", "FDA", "FDA-2015-D-2261", "Premarket Notification Requirements Concerning Gowns Intended for Use in Health Care Settings; Guidance for Industry and Food and Drug\nAdministration Staff; Availability", "Notice", "Notice of Availability", "2015-12-09T05:00:00Z", 2015, 12, "2015-12-09T05:00:00Z", null, "2015-12-09T14:59:09Z", "2015-30972", 0, 0, "0900006481d92624"], ["FDA-2015-N-0001-0108", "FDA", "FDA-2015-N-0001", "Psychopharmacologic Drugs Advisory Committee; Notice of Meeting", "Notice", "Meeting", "2015-12-09T05:00:00Z", 2015, 12, "2015-12-09T05:00:00Z", null, "2015-12-09T14:34:06Z", "2015-30970", 0, 0, "0900006481d92025"], ["FDA-2015-N-3015-0002", "FDA", "FDA-2015-N-3015", "Use of Databases for Establishing the Clinical Relevance of Human Genetic Variants; Public Workshop; Reopening of Comment Period", "Notice", "Meeting", "2015-12-09T05:00:00Z", 2015, 12, "2015-12-09T05:00:00Z", "2015-12-25T04:59:59Z", "2015-12-24T22:00:48Z", "2015-30936", 0, 0, "0900006481d92622"], ["FDA-2014-N-1286-0011", "FDA", "FDA-2014-N-1286", "Moving Forward: Collaborative Approaches to Medical Device\nCybersecurity; Public Workshop; Request for Comments", "Notice", "Meeting", "2015-12-07T05:00:00Z", 2015, 12, "2015-12-07T05:00:00Z", "2016-02-23T04:59:59Z", "2016-02-23T02:00:36Z", "2015-30772", 0, 0, "0900006481d89594"], ["FDA-2015-N-4399-0001", "FDA", "FDA-2015-N-4399", "Determination That OPHTHAINE (proparacaine hydrochloride) Solution\nand Other Drug Products Were Not Withdrawn From Sale for Reasons of\nSafety or Effectiveness", "Notice", "Determinations", "2015-12-04T05:00:00Z", 2015, 12, "2015-12-04T05:00:00Z", null, "2015-12-04T15:26:05Z", "2015-30628", 0, 0, "0900006481d85a4f"], ["FDA-2014-D-2175-0001", "FDA", "FDA-2014-D-2175", "Recommendations for Assessment of Blood Donor Suitability, Donor Deferral and Blood Product Management in Response to Ebola Virus; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2015-12-03T05:00:00Z", 2015, 12, "2015-12-03T05:00:00Z", "2015-03-03T04:59:59Z", "2015-12-03T15:01:08Z", "2015-30589", 0, 0, "0900006481d82bc1"], ["FDA-2010-N-0155-0222", "FDA", "FDA-2010-N-0155", "Veterinary Feed Directive Common Format Questions and Answers; Draft\nGuidance for Industry; Availability", "Notice", "Notice of Availability", "2015-12-01T05:00:00Z", 2015, 12, "2015-12-01T05:00:00Z", "2016-02-02T04:59:59Z", "2016-08-23T12:38:42Z", "2015-30411", 0, 0, "0900006481d7c706"], ["FDA-2015-N-0001-0107", "FDA", "FDA-2015-N-0001", "Psychopharmacologic Drugs Advisory Committee; Notice of Meeting", "Notice", "Meeting", "2015-11-30T05:00:00Z", 2015, 11, "2015-11-30T05:00:00Z", null, "2015-11-30T15:04:05Z", "2015-30296", 0, 0, "0900006481d7961c"], ["FDA-2015-N-0001-0106", "FDA", "FDA-2015-N-0001", "Vaccines and Related Biological Products Advisory Committee; Notice\nof Meeting", "Notice", "Meeting", "2015-11-27T05:00:00Z", 2015, 11, "2015-11-27T05:00:00Z", null, "2015-11-27T19:00:44Z", "2015-30121", 0, 0, "0900006481d762ed"], ["FDA-2015-N-4166-0001", "FDA", "FDA-2015-N-4166", "Public Meeting on Patient-Focused Drug Development for Psoriasis", "Notice", "Meeting", "2015-11-25T05:00:00Z", 2015, 11, "2015-11-25T05:00:00Z", "2016-05-18T03:59:59Z", "2016-05-18T04:00:33Z", "2015-29992", 0, 0, "0900006481d724c6"], ["FDA-2015-P-1153-0005", "FDA", "FDA-2015-P-1153", "Determination That TYLENOL WITH CODEINE (Acetaminophen With\nCodeine Phosphate) Oral Tablets, 325 Milligrams/7.5 Milligrams, 325\nMilligrams/15 Milligrams, 325 Milligrams/30 Milligrams, and 325\nMilligrams/60 Milligrams, Were Not Withdrawn From Sale for Reasons of\nSafety or Effectiveness", "Notice", "Determinations", "2015-11-25T05:00:00Z", 2015, 11, "2015-11-25T05:00:00Z", null, "2015-11-25T16:14:27Z", "2015-30051", 0, 0, "0900006481d72983"], ["FDA-2012-D-1197-0010", "FDA", "FDA-2012-D-1197", "Certification Process for Designated Medical Gases; Revised Draft\nGuidance for Industry; Availability", "Notice", "Notice of Availability", "2015-11-25T05:00:00Z", 2015, 11, "2015-11-25T05:00:00Z", "2016-01-26T04:59:59Z", "2016-01-25T22:01:02Z", "2015-29989", 0, 0, "0900006481d729d6"], ["FDA-2015-D-4272-0001", "FDA", "FDA-2015-D-4272", "Voluntary Labeling Indicating Whether Food Has or Has Not Been Derived From Genetically Engineered Atlantic Salmon; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2015-11-24T05:00:00Z", 2015, 11, "2015-11-24T05:00:00Z", "2016-01-26T04:59:59Z", "2016-05-31T18:45:30Z", "2015-29904", 0, 0, "0900006481d6d347"], ["FDA-2015-D-3990-0001", "FDA", "FDA-2015-D-3990", "Sunscreen Innovation Act: Section 586C(c) Advisory Committee Process;\nDraft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2015-11-23T05:00:00Z", 2015, 11, "2015-11-23T05:00:00Z", "2016-01-23T04:59:59Z", "2015-12-01T20:08:06Z", "2015-29635", 0, 0, "0900006481d6933a"], ["FDA-2015-N-0001-0105", "FDA", "FDA-2015-N-0001", "Orthopaedic and Rehabilitation Devices Panel of the Medical Devices\nAdvisory Committee; Notice of Meeting", "Notice", "Meeting", "2015-11-23T05:00:00Z", 2015, 11, "2015-11-23T05:00:00Z", null, "2015-11-23T14:24:47Z", "2015-29768", 0, 0, "0900006481d6881b"], ["FDA-2015-D-4033-0001", "FDA", "FDA-2015-D-4033", "Sunscreen Innovation Act: Nonprescription Sunscreen Drug\nProducts - Content and Format of Data Submissions; Draft Guidance for\nIndustry; Availability", "Notice", "Notice of Availability", "2015-11-23T05:00:00Z", 2015, 11, "2015-11-23T05:00:00Z", "2016-01-23T04:59:59Z", "2019-06-19T16:15:59Z", "2015-29637", 0, 0, "0900006481d6944a"], ["FDA-2015-D-4021-0001", "FDA", "FDA-2015-D-4021", "Over-the-Counter Sunscreens: Safety and Effectiveness Data; Draft\nGuidance for Industry; Availability", "Notice", "Notice of Availability", "2015-11-23T05:00:00Z", 2015, 11, "2015-11-23T05:00:00Z", "2016-01-23T04:59:59Z", "2015-12-20T00:54:08Z", "2015-29636", 0, 0, "0900006481d69941"], ["FDA-2015-D-4012-0001", "FDA", "FDA-2015-D-4012", "Sunscreen Innovation Act; Withdrawal of a 586A Request or Pending\nRequest; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2015-11-23T05:00:00Z", 2015, 11, "2015-11-23T05:00:00Z", "2016-01-23T04:59:59Z", "2015-12-01T20:18:02Z", "2015-29634", 0, 0, "0900006481d69942"], ["FDA-2015-P-3404-0004", "FDA", "FDA-2015-P-3404", "Determination That LIPTRUZET (Ezetimibe and Atorvastatin) Tablets,\n10 Milligrams/10 Milligrams, 10 Milligrams/20 Milligrams, 10\nMilligrams/40 Milligrams, and 10 Milligrams/80 Milligrams, Were Not\nWithdrawn From Sale for Reasons of Safety or Effectiveness", "Notice", "Determinations", "2015-11-20T05:00:00Z", 2015, 11, "2015-11-20T05:00:00Z", null, "2015-12-01T20:22:32Z", "2015-29639", 0, 0, "0900006481d5e0b2"], ["FDA-2012-N-0145-0007", "FDA", "FDA-2012-N-0145", "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Improving Food Safety and Defense Capacity of the State and Local Level: Review of State and Local Capacities", "Notice", "30 Day Proposed Information Collection", "2015-11-20T05:00:00Z", 2015, 11, "2015-11-20T05:00:00Z", "2015-12-22T04:59:59Z", "2015-11-20T14:55:23Z", "2015-29663", 0, 0, "0900006481d5e13e"], ["FDA-2015-M-2217-0002", "FDA", "FDA-2015-M-2217", "Medical Devices: Availability of Safety and Effectiveness Summaries for Premarket Approval Applications", "Notice", "Notice of Approval", "2015-11-18T05:00:00Z", 2015, 11, "2015-11-18T05:00:00Z", null, "2024-11-11T21:11:27Z", "2015-29450", 1, 0, "0900006481d56a57"], ["FDA-2015-M-2219-0002", "FDA", "FDA-2015-M-2219", "Medical Devices: Availability of Safety and Effectiveness Summaries for Premarket Approval Applications", "Notice", "Notice of Approval", "2015-11-18T05:00:00Z", 2015, 11, "2015-11-18T05:00:00Z", null, "2024-11-07T23:33:15Z", "2015-29450", 1, 0, "0900006481d56a5b"], ["FDA-2015-M-2618-0002", "FDA", "FDA-2015-M-2618", "Medical Devices: Availability of Safety and Effectiveness Summaries for Premarket Approval Applications", "Notice", "Notice of Approval", "2015-11-18T05:00:00Z", 2015, 11, "2015-11-18T05:00:00Z", null, "2024-11-07T23:33:15Z", "2015-29450", 1, 0, "0900006481d56a5f"], ["FDA-2015-M-2739-0002", "FDA", "FDA-2015-M-2739", "Medical Devices: Availability of Safety and Effectiveness Summaries for Premarket Approval Applications", "Notice", "Notice of Approval", "2015-11-18T05:00:00Z", 2015, 11, "2015-11-18T05:00:00Z", null, "2024-11-07T23:34:52Z", "2015-29450", 1, 0, "0900006481d56bc9"], ["FDA-2015-M-2218-0002", "FDA", "FDA-2015-M-2218", "Medical Devices: Availability of Safety and Effectiveness Summaries for Premarket Approval Applications", "Notice", "Notice of Approval", "2015-11-18T05:00:00Z", 2015, 11, "2015-11-18T05:00:00Z", null, "2024-11-11T21:12:23Z", "2015-29450", 1, 0, "0900006481d56a56"], ["FDA-2015-M-2634-0002", "FDA", "FDA-2015-M-2634", "Medical Devices: Availability of Safety and Effectiveness Summaries for Premarket Approval Applications", "Notice", "Notice of Approval", "2015-11-18T05:00:00Z", 2015, 11, "2015-11-18T05:00:00Z", null, "2024-11-07T23:33:14Z", "2015-29450", 1, 0, "0900006481d56a5d"], ["FDA-2015-M-1707-0002", "FDA", "FDA-2015-M-1707", "Medical Devices: Availability of Safety and Effectiveness Summaries for Premarket Approval Applications", "Notice", "Notice of Approval", "2015-11-18T05:00:00Z", 2015, 11, "2015-11-18T05:00:00Z", null, "2024-11-07T23:35:03Z", "2015-29450", 1, 0, "0900006481d5485a"], ["FDA-2015-M-2497-0002", "FDA", "FDA-2015-M-2497", "Medical Devices: Availability of Safety and Effectiveness Summaries for Premarket Approval Applications", "Notice", "Notice of Approval", "2015-11-18T05:00:00Z", 2015, 11, "2015-11-18T05:00:00Z", null, "2024-11-07T23:33:16Z", "2015-29450", 1, 0, "0900006481d56a5a"], ["FDA-2008-D-0530-0014", "FDA", "FDA-2008-D-0530", "Agency Information Collection Activities; Proposals, Submissions, and Approvals: Guidance for Industry on Tropical Disease Priority Review Vouchers", "Notice", "30 Day Proposed Information Collection", "2015-11-18T05:00:00Z", 2015, 11, "2015-11-18T05:00:00Z", "2015-12-19T04:59:59Z", "2015-11-18T16:33:38Z", "2015-29406", 0, 0, "0900006481d5490d"], ["FDA-2012-N-0921-0003", "FDA", "FDA-2012-N-0921", "Agency Information Collection Activities; Proposed Collection;\nComment Request; Adverse Event Reporting; Electronic Submissions", "Notice", "60 Day Proposed Information Collection", "2015-11-18T05:00:00Z", 2015, 11, "2015-11-18T05:00:00Z", "2016-01-20T04:59:59Z", "2015-11-18T16:39:20Z", "2015-29407", 0, 0, "0900006481d54910"], ["FDA-2015-M-2499-0002", "FDA", "FDA-2015-M-2499", "Medical Devices: Availability of Safety and Effectiveness Summaries for Premarket Approval Applications", "Notice", "Notice of Approval", "2015-11-18T05:00:00Z", 2015, 11, "2015-11-18T05:00:00Z", null, "2024-11-07T23:33:15Z", "2015-29450", 1, 0, "0900006481d56a5c"], ["FDA-2013-D-0286-0014", "FDA", "FDA-2013-D-0286", "Formal Meetings Between the Food and Drug Administration and\nBiosimilar Biological Product Sponsors or Applicants; Guidance for\nIndustry; Availability", "Notice", "Notice of Availability", "2015-11-18T05:00:00Z", 2015, 11, "2015-11-18T05:00:00Z", null, "2015-11-18T16:29:20Z", "2015-29455", 0, 0, "0900006481d54890"], ["FDA-2015-M-2964-0002", "FDA", "FDA-2015-M-2964", "Medical Devices: Availability of Safety and Effectiveness Summaries for Premarket Approval Applications", "Notice", "Notice of Approval", "2015-11-18T05:00:00Z", 2015, 11, "2015-11-18T05:00:00Z", null, "2024-11-07T23:34:01Z", "2015-29450", 1, 0, "0900006481d56bcb"], ["FDA-2015-M-2584-0002", "FDA", "FDA-2015-M-2584", "Medical Devices: Availability of Safety and Effectiveness Summaries for Premarket Approval Applications", "Notice", "Notice of Approval", "2015-11-18T05:00:00Z", 2015, 11, "2015-11-18T05:00:00Z", null, "2024-11-07T23:34:52Z", "2015-29450", 1, 0, "0900006481d56a5e"], ["FDA-2015-M-2740-0002", "FDA", "FDA-2015-M-2740", "Medical Devices: Availability of Safety and Effectiveness Summaries for Premarket Approval Applications", "Notice", "Notice of Approval", "2015-11-18T05:00:00Z", 2015, 11, "2015-11-18T05:00:00Z", null, "2024-11-07T23:34:00Z", "2015-29450", 1, 0, "0900006481d56bca"], ["FDA-2014-N-0229-0007", "FDA", "FDA-2014-N-0229", "Issuance of Priority Review Voucher; Rare Pediatric Disease Product", "Notice", "Announcement", "2015-11-17T05:00:00Z", 2015, 11, "2015-11-17T05:00:00Z", null, "2016-10-03T15:07:12Z", "2015-29280", 0, 0, "0900006481d4d4cc"], ["FDA-2012-D-0529-0004", "FDA", "FDA-2012-D-0529", "Organ-Specific Warnings: Internal Analgesic, Antipyretic, and\nAntirheumatic Drug Products for Overthe-Counter Human Use\u2014Labeling for Products That Contain Acetaminophen; Guidance for\nIndustry; Availability", "Notice", "Notice of Availability", "2015-11-17T05:00:00Z", 2015, 11, "2015-11-17T05:00:00Z", null, "2015-11-17T14:30:25Z", "2015-29281", 0, 0, "0900006481d4d3e9"], ["FDA-2015-N-0986-0038", "FDA", "FDA-2015-N-0986", "Center for Devices and Radiological Health: Experiential Learning Program;\nGeneral Training Program", "Notice", "Announcement", "2015-11-16T05:00:00Z", 2015, 11, "2015-11-16T05:00:00Z", "2015-12-17T04:59:59Z", "2015-12-17T22:00:26Z", "2015-28857", 0, 0, "0900006481d488b6"], ["FDA-2015-N-0001-0104", "FDA", "FDA-2015-N-0001", "Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee; Amendment of Notice", "Notice", "Meeting Postponement", "2015-11-16T05:00:00Z", 2015, 11, "2015-11-16T05:00:00Z", null, "2015-11-16T16:07:25Z", "2015-28846", 0, 0, "0900006481d48d0a"], ["FDA-2009-N-0394-0004", "FDA", "FDA-2009-N-0394", "Request for Nominations for Voting Members on a Public Advisory\nCommittee; Tobacco Products Scientific Advisory Committee", "Notice", "Request for Nominations", "2015-11-16T05:00:00Z", 2015, 11, "2015-11-16T05:00:00Z", null, "2015-11-16T14:55:20Z", "2015-28847", 0, 0, "0900006481d48817"], ["FDA-1977-N-0356-0016", "FDA", "FDA-1977-N-0356", "Drugs for Human Use; Drug Efficacy Study Implementation; Nitroglycerin\nTransdermal Systems; Withdrawal of Hearing Request; Withdrawal of\nApplications; Final Resolution of Hearing Requests Regarding\nTransdermal Systems Under Docket", "Notice", "Announcement", "2015-11-16T05:00:00Z", 2015, 11, "2015-11-16T05:00:00Z", null, "2024-11-07T23:35:36Z", "2015-28853", 1, 0, "0900006481d488ba"], ["FDA-2015-N-3972-0001", "FDA", "FDA-2015-N-3972", "Eighth Annual Sentinel Initiative; Public Workshop; Request for\nComments", "Notice", "Meeting", "2015-11-16T05:00:00Z", 2015, 11, "2015-11-16T05:00:00Z", "2016-04-05T03:59:59Z", "2015-11-16T15:55:47Z", "2015-28851", 0, 0, "0900006481d48d06"], ["FDA-2012-N-0564-0004", "FDA", "FDA-2012-N-0564", "Agency Information Collection Activities; Submission for Office of\nManagement and Budget Review; Comment Request; Dietary\nSupplement Labeling Requirements and Recommendations Under the\nDietary Supplement and Nonprescription Drug Consumer Protection Act", "Notice", "30 Day Proposed Information Collection", "2015-11-13T05:00:00Z", 2015, 11, "2015-11-13T05:00:00Z", "2015-12-15T04:59:59Z", "2015-12-11T22:00:21Z", "2015-28788", 0, 0, "0900006481d4039a"], ["FDA-2011-N-0920-2046", "FDA", "FDA-2011-N-0920", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approval; Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Human Food", "Notice", "Notice of Approval", "2015-11-13T05:00:00Z", 2015, 11, "2015-11-13T05:00:00Z", null, "2015-11-13T14:45:48Z", "2015-28790", 0, 0, "0900006481d40340"], ["FDA-2013-D-1630-0009", "FDA", "FDA-2013-D-1630", "Guidance on Qualification of Biomarker\u2014Galactomannan in Studies\nof Treatments of Invasive Aspergillosis; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2015-11-13T05:00:00Z", 2015, 11, "2015-11-13T05:00:00Z", "2016-01-13T04:59:59Z", "2016-01-13T22:00:55Z", "2015-28804", 0, 0, "0900006481d3f8ea"], ["FDA-2012-D-0049-0030", "FDA", "FDA-2012-D-0049", "Agency Information Collection Activities; Proposed Collection;\nComment Request; Reporting Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke Under the Federal Food, Drug, and Cosmetic Act", "Notice", "60 Day Proposed Information Collection", "2015-11-13T05:00:00Z", 2015, 11, "2015-11-13T05:00:00Z", "2016-01-13T04:59:59Z", "2016-02-29T17:52:47Z", "2015-28787", 0, 0, "0900006481d3f8e7"], ["FDA-2011-N-0922-0552", "FDA", "FDA-2011-N-0922", "Agency Information Collection Activities; Announcement of Office of\nManagement and Budget Approval; Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Food for\nAnimals", "Notice", "Notice of Approval", "2015-11-13T05:00:00Z", 2015, 11, "2015-11-13T05:00:00Z", null, "2015-11-13T14:19:44Z", "2015-28789", 0, 0, "0900006481d401f1"], ["FDA-2015-D-3638-0002", "FDA", "FDA-2015-D-3638", "Minutes of Institutional Review Board Meetings: Guidance for Institutions\nand Institutional Review Boards; Draft Guidance; Availability", "Notice", "Notice of Availability", "2015-11-12T05:00:00Z", 2015, 11, "2015-11-12T05:00:00Z", "2016-01-05T04:59:59Z", "2015-12-21T22:00:22Z", null, 0, 0, "0900006481d39851"], ["FDA-2015-N-0001-0103", "FDA", "FDA-2015-N-0001", "Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting", "Notice", "Meeting", "2015-11-12T05:00:00Z", 2015, 11, "2015-11-12T05:00:00Z", null, "2015-11-12T14:30:05Z", "2015-28672", 0, 0, "0900006481d3872e"]], "truncated": false, "filtered_table_rows_count": 869, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"document_type\" = :p1 and \"posted_year\" = :p2 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "Notice", "p2": "2015"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2015", "results": [{"value": "FDA", "label": "FDA", "count": 869, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?document_type=Notice&posted_year=2015", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2015", "results": [{"value": "Notice", "label": "Notice", "count": 869, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&posted_year=2015", "selected": true}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2015", "results": [{"value": 2015, "label": 2015, "count": 869, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2015&_facet=posted_month"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2015&_facet=open_for_comment"}, {"name": "withdrawn", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2015&_facet=withdrawn"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2015&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2015&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2015&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2015&_facet_date=last_modified"}], "next": "2015-11-12T05~3A00~3A00Z,FDA-2015-N-0001-0103", "next_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&document_type=Notice&posted_year=2015&_next=2015-11-12T05~3A00~3A00Z%2CFDA-2015-N-0001-0103&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 1335.6193569488823, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}